InvestorsHub Logo
Followers 46
Posts 1362
Boards Moderated 0
Alias Born 08/09/2015

Re: A deleted message

Saturday, 04/15/2023 10:43:12 AM

Saturday, April 15, 2023 10:43:12 AM

Post# of 459726
Exactly, Ma’s appointment as independent Chairman of the Board is great news. This is a significant event for Anavex and its shareholders. The below excerpt is from the May 2021 appointment of Ma to Anavex’s board. She has been serving as a board member of Anavex for almost two years, which adds to her other impressive background set forth below:

Anavex Life Sciences Announces Appointment of Ms Jiong Ma, PhD to Board of Directors

Published: May 26, 2021

...Ms. Ma is Senior Board executive with over 25 years of experience in investing, building, scaling of companies with focus on innovative product launches in digital health, technology and the new energy transition. Dr. Jiong Ma serves and served as a Board Director of LinkinVax, Aledia, Voxel8, Lo3 Energy, mc10, acquired by Medidata, Storiant, Fulham, Convey Computer, acquired by Micron Technology, Powervation, acquired by RHOM Semiconductor, Laser Light Engine and Carbonite, Inc., which went public via IPO in 2011 and was subsequently acquired by OpenText in 2019 for approximately $1.45 billion.

As a Partner at Braemar Energy Ventures ($600 million AUM), Ms. Ma focused on investments in digitization of industry, resource efficiency, mobility, renewable energy infrastructure, and deeptech. She was on the firm’s investment committee and has led more than 15 investments in growth stage companies with focus on innovative product launches, as well as raising funding, negotiating and structuring investments, hiring management teams, and assembling boards.

Prior, she was with the Venture Capital Group at 3i, a global private equity firm ($17 billion AUM), where she led investments across multiple stages in Digital Health, TMT and Cleantech. Among them TransMedics Group (Nasdaq: TMDX), ImpactRx/Symphony Health Solutions, which was later acquired by PRA Health Sciences (Nasdaq:PRAH).

Preceding the Venture Capital Group at 3i, Ms. Ma held several senior positions at Lucent Technologies and Bell Labs. Her responsibilities included lead roles in product portfolio strategy, new product launches for Optical and Data Networking, and research and product development. Ms. Ma was also a founding team member of Onetta, a fiber networks company.

She has a PhD in Electrical and Computer Engineering from the University Colorado at Boulder and an MS in Electrical Engineering from Worcester Polytechnic Institute. Ms. Ma is a Kauffman Fellow.

“It’s an honor to join Anavex’s Board of Directors,” said Ms. Ma. “With the focus on neurodegeneration and neurodevelopmental diseases, Anavex is tackling one of the biggest medical challenges that our society faces today. I am impressed with the breadth of Anavex’s pipeline. I look forward to applying my insights to advance Anavex towards its next stage of growth on the way to commercial success.”


https://www.biospace.com/article/releases/anavex-life-sciences-announces-appointment-of-ms-jiong-ma-phd-to-board-of-directors/

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News